Related Experiment Video
Updated: Jan 16, 2026

Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System
Published on: December 11, 2016
How to make one line in the FDA Commissioner's new drug review program into a force for affordable access for
Sarah K Emond1, Daniel A Ollendorf1
1Institute for Clinical and Economic Review, Boston, MA 02108, United States.
Abstract:
The FDA Commissioner's new National Priority Voucher program seeks to accelerate drug approvals for products meeting certain criteria. Interestingly, the program intends to increase affordability of new drugs. With few specifics available as to how the program will achieve that goal, this paper proposes a framework for leveraging independent value assessments to achieve affordable access while incentivizing evidence development and innovation.
Related Concept Videos
Drug Regulation
Drug Control Governance: Regulatory Bodies and Their Impact
Drug Products: Biologics, Biosimilars and Interchangeables
Prescription, Nonprescription and Orphan Drugs
The misuse and addiction to prescription drugs is a growing problem that can affect people of all age groups, specifically teenagers. This can happen when prescription medications are used in ways not intended by the prescriber, such as taking someone else's prescription or using medication for...
Drug Discovery: Overview
FDA Approved Drugs: Changes to Approved Drugs

